268 related articles for article (PubMed ID: 38097330)
1. Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes.
Yang H; Sieben CJ; Schauer RS; Harris PC
Adv Kidney Dis Health; 2023 Sep; 30(5):397-406. PubMed ID: 38097330
[TBL] [Abstract][Full Text] [Related]
2. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
Senum SR; Li YSM; Benson KA; Joli G; Olinger E; Lavu S; Madsen CD; Gregory AV; Neatu R; Kline TL; Audrézet MP; Outeda P; Nau CB; Meijer E; Ali H; Steinman TI; Mrug M; Phelan PJ; Watnick TJ; Peters DJM; Ong ACM; Conlon PJ; Perrone RD; Cornec-Le Gall E; Hogan MC; Torres VE; Sayer JA; ; Harris PC
Am J Hum Genet; 2022 Jan; 109(1):136-156. PubMed ID: 34890546
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
[TBL] [Abstract][Full Text] [Related]
4. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E; Torres VE; Harris PC
J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
[TBL] [Abstract][Full Text] [Related]
5. Early and Severe Polycystic Kidney Disease and Related Ciliopathies: An Emerging Field of Interest.
Bergmann C
Nephron; 2019; 141(1):50-60. PubMed ID: 30359986
[TBL] [Abstract][Full Text] [Related]
6. Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.
Chang AR; Moore BS; Luo JZ; Sartori G; Fang B; Jacobs S; Abdalla Y; Taher M; Carey DJ; Triffo WJ; Singh G; Mirshahi T
JAMA; 2022 Dec; 328(24):2412-2421. PubMed ID: 36573973
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
8. Cilia and polycystic kidney disease.
Ma M
Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
[TBL] [Abstract][Full Text] [Related]
9. Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.
Al-Hamed MH; Alsahan N; Rice SJ; Edwards N; Nooreddeen E; Alotaibi M; Kurdi W; Alnemer M; Altaleb N; Ali W; Al-Numair N; Almejaish N; Sayer JA; Imtiaz F
Pediatr Nephrol; 2019 Sep; 34(9):1615-1623. PubMed ID: 31079206
[TBL] [Abstract][Full Text] [Related]
10. Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Delbarba E; Econimo L; Dordoni C; Martin E; Mazza C; Savoldi G; Alberici F; Scolari F; Izzi C
J Nephrol; 2022 Mar; 35(2):645-652. PubMed ID: 34357571
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype of autosomal dominant polycystic kidney disease in Malta.
Ciantar N; Zahra G; Delicata J; Sammut F; Calleja-Agius J; Farrugia E; Said E
Eur J Med Genet; 2024 Mar; 69():104934. PubMed ID: 38537868
[TBL] [Abstract][Full Text] [Related]
12. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
[TBL] [Abstract][Full Text] [Related]
13. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies.
Bergmann C
Pediatr Nephrol; 2015 Jan; 30(1):15-30. PubMed ID: 24584572
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Genetic Interactions between
Olson RJ; Hopp K; Wells H; Smith JM; Furtado J; Constans MM; Escobar DL; Geurts AM; Torres VE; Harris PC
J Am Soc Nephrol; 2019 Nov; 30(11):2113-2127. PubMed ID: 31427367
[TBL] [Abstract][Full Text] [Related]
15. Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.
Mantovani V; Bin S; Graziano C; Capelli I; Minardi R; Aiello V; Ambrosini E; Cristalli CP; Mattiaccio A; Pariali M; De Fanti S; Faletra F; Grosso E; Cantone R; Mancini E; Mencarelli F; Pasini A; Wischmeijer A; Sciascia N; Seri M; La Manna G
Front Genet; 2020; 11():464. PubMed ID: 32457805
[No Abstract] [Full Text] [Related]
16. Autosomal recessive and dominant polycystic kidney diseases.
Sessa A; Righetti M; Battini G
Minerva Urol Nefrol; 2004 Dec; 56(4):329-38. PubMed ID: 15785425
[TBL] [Abstract][Full Text] [Related]
17. The Clinical and Mutational Spectrum of 69 Turkish Children with Autosomal Recessive or Autosomal Dominant Polycystic Kidney Disease: A Multicenter Retrospective Cohort Study.
Tutal O; Gulhan B; Atayar E; Yuksel S; Ozcakar ZB; Soylemezoglu O; Saygili S; Caliskan S; Inozu M; Baskin E; Duzova A; Hayran M; Topaloglu R; Ozaltin F
Nephron; 2024; 148(5):319-332. PubMed ID: 36657418
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the molecular diagnosis of polycystic kidney disease.
Bergmann C
Expert Rev Mol Diagn; 2017 Dec; 17(12):1037-1054. PubMed ID: 28952822
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
